Why is Acadia Healthcare Company (ACHC) Highly Favored by Hedge Funds

Acadia Healthcare Company Inc. (NASDAQ:ACHC) is one of the 10 most promising mid-cap healthcare stocks according to hedge funds.

On May 4, following a strong first-quarter report, Raymond James upgraded its rating on Acadia Healthcare Company, Inc. (NASDAQ:ACHC) from Outperform to Strong Buy. The firm also adjusted its price target upward from $25 to $39, resulting in an adjusted upside of more than 67%.

The firm noted that Acadia modestly increased its 2026 earnings and EBITDA guidance. It believes that the company is well-positioned for estimate revisions and elevated valuation multiples, as it works to extract a $200 million target from underperforming locations while maintaining a modest growth trajectory.

On May 1, Cantor Fitzgerald increased the target price on Acadia Healthcare Company Inc. (NASDAQ:ACHC) from $20 to $30, while reiterating a Neutral rating on the shares. This yields a revised upside potential of roughly 29% at the prevailing level.

According to an investor brief reported by the firm, escalating bad debt and denial patterns are neutralizing operational improvements. Although concentrated among specific insurance providers and regions, these trends continue to create ambiguity around the short-term outlook despite some positive core operational performance.

Acadia Healthcare Company Inc. (NASDAQ:ACHC) provides behavioral healthcare services in the U.S. and Puerto Rico. The company runs various facilities, including acute inpatient psychiatric centers, residential recovery and eating disorder facilities, comprehensive treatment centers, and residential treatment centers. It also facilitates outpatient behavioral healthcare services addressing the mental health and recovery needs of communities.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

Disclosure: None. Follow Insider Monkey on Google News.